| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.613 | 0.05 | 0.616 | Antiinflammatory | 0.616 0.049 CID_154699915 | CID_154699915 | |
| 0.57 | 0.023 | 0.687 | Aldehyde oxidase inhibitor | 0.687 0.009 CID_154699915 | CID_154699915 | |
| 0.503 | 0.008 | 0.503 | Anesthetic general | 0.502 0.008 CID_154699915 | ||
| 0.485 | 0.037 | 0.485 | 5 Hydroxytryptamine release inhibitor | 0.479 0.04 CID_154699915 | ||
| 0.431 | 0.006 | 0.431 | Cyclooxygenase 1 inhibitor | 0.418 0.006 CID_154699915 | ||
| 0.444 | 0.025 | 0.458 | Interleukin antagonist | 0.458 0.023 CID_154699915 | CID_154699915 | |
| 0.412 | 0.012 | 0.412 | Non-steroidal antiinflammatory agent | 0.41 0.012 CID_154699915 | ||
| 0.387 | 0.004 | 0.436 | Cyclooxygenase 3 inhibitor | 0.436 0.004 CID_154699915 | CID_154699915 | |
| 0.363 | 0.016 | 0.363 | Src kinase inhibitor | 0.312 0.024 CID_154699915 | ||
| 0.335 | 0.004 | 0.359 | Interleukin 8 antagonist | 0.359 0.004 CID_154699915 | CID_154699915 | |
| 0.342 | 0.012 | 0.342 | Cyclooxygenase inhibitor | 0.328 0.014 CID_154699915 | ||
| 0.327 | 0.007 | 0.327 | Succinate dehydrogenase inhibitor | 0.318 0.008 CID_154699915 | ||
| 0.37 | 0.057 | 0.414 | Cholesterol antagonist | 0.414 0.047 CID_154699915 | CID_154699915 | |
| 0.31 | 0.016 | 0.31 | Lck kinase inhibitor | 0.252 0.024 CID_154699915 | ||
| 0.38 | 0.093 | 0.38 | Analgesic | 0.357 0.105 CID_154699915 | ||
| 0.307 | 0.033 | 0.307 | MAP kinase kinase 2 inhibitor | 0.272 0.045 CID_154699915 | ||
| 0.325 | 0.059 | 0.452 | Lipoxygenase inhibitor | 0.452 0.026 CID_154699915 | CID_154699915 | |
| 0.301 | 0.041 | 0.313 | Cyclic AMP phosphodiesterase inhibitor | 0.313 0.037 CID_154699915 | CID_154699915 | |
| 0.269 | 0.01 | 0.278 | ATPase inhibitor | 0.278 0.008 CID_154699915 | CID_154699915 | |
| 0.262 | 0.018 | 0.262 | Cyclooxygenase 2 inhibitor | 0.244 0.021 CID_154699915 | ||
| 0.252 | 0.008 | 0.266 | Potassium channel (Ca-activated) activator | 0.266 0.007 CID_154699915 | CID_154699915 | |
| 0.246 | 0.006 | 0.247 | Arachidonic acid antagonist | 0.247 0.006 CID_154699915 | CID_154699915 | |
| 0.365 | 0.134 | 0.444 | Caspase 9 stimulant | 0.444 0.086 CID_154699915 | CID_154699915 | |
| 0.244 | 0.013 | 0.3 | Carbonic anhydrase XV inhibitor | 0.3 0.008 CID_154699915 | CID_154699915 | |
| 0.244 | 0.016 | 0.244 | MAP kinase kinase inhibitor | 0.233 0.019 CID_154699915 | ||
| 0.258 | 0.042 | 0.258 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.242 0.049 CID_154699915 | ||
| 0.217 | 0.009 | 0.217 | HIV-1 integrase (Overall Integration) inhibitor | 0.216 0.009 CID_154699915 | ||
| 0.291 | 0.101 | 0.291 | Calcium channel activator | 0.288 0.104 CID_154699915 | ||
| 0.22 | 0.033 | 0.231 | Phospholipase A2 inhibitor | 0.231 0.029 CID_154699915 | CID_154699915 | |
| 0.188 | 0.006 | 0.188 | MAP kinase kinase 1 inhibitor | 0.172 0.01 CID_154699915 | ||
| 0.191 | 0.01 | 0.191 | Potassium channel activator | 0.149 0.02 CID_154699915 | ||
| 0.19 | 0.011 | 0.19 | Sphingosine 1-phosphate receptor 4 antagonist | 0.165 0.022 CID_154699915 | ||
| 0.21 | 0.031 | 0.21 | Alpha-N-acetylglucosaminidase inhibitor | 0.119 0.078 CID_154699915 | ||
| 0.215 | 0.041 | 0.215 | Protein-tyrosine kinase Lyn inhibitor | 0.157 0.062 CID_154699915 | ||
| 0.321 | 0.158 | 0.321 | MAP kinase 1 inhibitor | 0.287 0.195 CID_154699915 | ||
| 0.285 | 0.125 | 0.285 | Immunosuppressant | 0.276 0.13 CID_154699915 | ||
| 0.286 | 0.126 | 0.336 | GABA C receptor rho-3 antagonist | 0.336 0.094 CID_154699915 | CID_154699915 | |
| 0.22 | 0.06 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 CID_154699915 | CID_154699915 | |
| 0.196 | 0.036 | 0.196 | c-Src kinase inhibitor | 0.184 0.04 CID_154699915 | ||
| 0.202 | 0.043 | 0.202 | Diuretic | 0.164 0.065 CID_154699915 | ||
| 0.19 | 0.037 | 0.19 | Interleukin 1 antagonist | 0.178 0.043 CID_154699915 | ||
| 0.327 | 0.178 | 0.327 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.24 | 0.092 | 0.24 | 5 Hydroxytryptamine uptake stimulant | 0.237 0.095 CID_154699915 | ||
| 0.239 | 0.092 | 0.239 | Gastrin inhibitor | |||
| 0.158 | 0.013 | 0.211 | Adrenaline agonist | 0.211 0.006 CID_154699915 | CID_154699915 | |
| 0.232 | 0.088 | 0.286 | Tyrosine 3 hydroxylase inhibitor | 0.286 0.041 CID_154699915 | CID_154699915 | |
| 0.216 | 0.074 | 0.216 | ErbB-1 antagonist | 0.214 0.076 CID_154699915 | ||
| 0.2 | 0.059 | 0.399 | Peroxidase inhibitor | 0.399 0.021 CID_154699915 | CID_154699915 | |
| 0.156 | 0.016 | 0.156 | Interleukin 2 antagonist | 0.132 0.03 CID_154699915 | ||
| 0.158 | 0.019 | 0.25 | Carbonic anhydrase VI inhibitor | 0.25 0.009 CID_154699915 | CID_154699915 | |
| 0.15 | 0.011 | 0.15 | Prostaglandin-E synthase inhibitor | 0.136 0.015 CID_154699915 | ||
| 0.175 | 0.039 | 0.175 | MAP kinase 3 inhibitor | 0.144 0.077 CID_154699915 | ||
| 0.14 | 0.008 | 0.14 | Elastase 1 inhibitor | 0.126 0.01 CID_154699915 | ||
| 0.139 | 0.011 | 0.139 | Sphingosine 1-phosphate receptor 4 agonist | 0.116 0.018 CID_154699915 | ||
| 0.148 | 0.02 | 0.148 | Electrolyte absorption antagonist | 0.097 0.062 CID_154699915 | ||
| 0.18 | 0.057 | 0.18 | Polo-like kinase-3 inhibitor | 0.157 0.077 CID_154699915 | ||
| 0.163 | 0.042 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | 0.149 0.063 CID_154699915 | ||
| 0.143 | 0.03 | 0.143 | Gastric antisecretory | 0.133 0.035 CID_154699915 | ||
| 0.142 | 0.029 | 0.142 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.067 CID_154699915 | ||
| 0.221 | 0.109 | 0.248 | Immunostimulant | 0.248 0.097 CID_154699915 | CID_154699915 | |
| 0.126 | 0.015 | 0.126 | Potassium channel large-conductance Ca-activated activator | 0.126 0.015 CID_154699915 | ||
| 0.151 | 0.04 | 0.151 | Interleukin 1b antagonist | 0.13 0.055 CID_154699915 | ||
| 0.257 | 0.15 | 0.291 | Histamine release inhibitor | 0.291 0.128 CID_154699915 | CID_154699915 | |
| 0.167 | 0.061 | 0.175 | Hexokinase inhibitor | 0.175 0.053 CID_154699915 | CID_154699915 | |
| 0.214 | 0.11 | 0.214 | 5 Hydroxytryptamine release stimulant | 0.198 0.123 CID_154699915 | ||
| 0.127 | 0.023 | 0.144 | Interleukin 12 antagonist | 0.144 0.014 CID_154699915 | CID_154699915 | |
| 0.168 | 0.066 | 0.168 | Interleukin 6 antagonist | 0.167 0.067 CID_154699915 | ||
| 0.226 | 0.125 | 0.335 | 12-Lipoxygenase inhibitor | 0.335 0.063 CID_154699915 | CID_154699915 | |
| 0.105 | 0.005 | 0.106 | CXC chemokine 1 receptor antagonist | 0.106 0.005 CID_154699915 | CID_154699915 | |
| 0.124 | 0.027 | 0.124 | Vanilloid antagonist | 0.111 0.031 CID_154699915 | ||
| 0.167 | 0.071 | 0.181 | Catenin beta inhibitor | 0.181 0.051 CID_154699915 | CID_154699915 | |
| 0.131 | 0.034 | 0.174 | Creatine kinase inhibitor | 0.174 0.016 CID_154699915 | CID_154699915 | |
| 0.146 | 0.053 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 CID_154699915 | ||
| 0.149 | 0.055 | 0.149 | Pregnane X receptor agonist | 0.136 0.083 CID_154699915 | ||
| 0.104 | 0.012 | 0.104 | Phosphorylase inhibitor | 0.099 0.013 CID_154699915 | ||
| 0.113 | 0.022 | 0.113 | Vanilloid 1 antagonist | 0.08 0.037 CID_154699915 | ||
| 0.18 | 0.088 | 0.18 | Focal adhesion kinase 2 inhibitor | |||
| 0.101 | 0.01 | 0.101 | Factor IXa inhibitor | 0.085 0.014 CID_154699915 | ||
| 0.237 | 0.147 | 0.256 | Vasodilator, coronary | 0.256 0.129 CID_154699915 | CID_154699915 | |
| 0.119 | 0.03 | 0.119 | Platelet growth factor antagonist | 0.103 0.039 CID_154699915 | ||
| 0.103 | 0.015 | 0.103 | NMDA receptor glycine site agonist | 0.069 0.037 CID_154699915 | ||
| 0.136 | 0.049 | 0.136 | CC chemokine 6 receptor antagonist | 0.134 0.056 CID_154699915 | ||
| 0.136 | 0.051 | 0.136 | Protein kinase (CK2) alpha inhibitor | 0.129 0.056 CID_154699915 | ||
| 0.112 | 0.028 | 0.123 | Bile acid receptor antagonist | 0.123 0.018 CID_154699915 | CID_154699915 | |
| 0.124 | 0.041 | 0.124 | UDP-glucose 4-epimerase inhibitor | 0.106 0.055 CID_154699915 | ||
| 0.13 | 0.047 | 0.13 | Ferrochelatase inhibitor | |||
| 0.117 | 0.034 | 0.117 | Potassium channel (Voltage-sensitive) activator | |||
| 0.225 | 0.147 | 0.314 | Transcription factor NF kappa B inhibitor | 0.314 0.088 CID_154699915 | CID_154699915 | |
| 0.12 | 0.043 | 0.12 | MAP kinase 8 inhibitor | 0.087 0.077 CID_154699915 | ||
| 0.19 | 0.112 | 0.207 | Peptidyltransferase inhibitor | 0.207 0.09 CID_154699915 | CID_154699915 | |
| 0.113 | 0.037 | 0.113 | Triose-phosphate isomerase inhibitor | 0.083 0.071 CID_154699915 | ||
| 0.11 | 0.034 | 0.11 | NADH dehydrogenase inhibitor | 0.094 0.051 CID_154699915 | ||
| 0.094 | 0.018 | 0.101 | CDC25B inhibitor | 0.101 0.015 CID_154699915 | CID_154699915 | |
| 0.151 | 0.077 | 0.172 | Interferon gamma antagonist | 0.172 0.056 CID_154699915 | CID_154699915 | |
| 0.183 | 0.112 | 0.272 | Antiamyloidogenic | 0.272 0.062 CID_154699915 | CID_154699915 | |
| 0.09 | 0.018 | 0.09 | Alpha 2 adrenoreceptor agonist | 0.087 0.02 CID_154699915 | ||
| 0.219 | 0.149 | 0.219 | Angiogenesis inhibitor | 0.219 0.149 CID_154699915 | ||
| 0.09 | 0.021 | 0.09 | Potassium channel (ATP-sensitive) blocker | 0.082 0.026 CID_154699915 | ||
| 0.086 | 0.017 | 0.094 | NMDA 2A receptor antagonist | 0.094 0.015 CID_154699915 | CID_154699915 | |
| 0.081 | 0.014 | 0.081 | Protein kinase C theta inhibitor | 0.065 0.029 CID_154699915 | ||
| 0.075 | 0.009 | 0.075 | Fructose-1,6-bisphosphatase inhibitor | 0.065 0.014 CID_154699915 | ||
| 0.109 | 0.043 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.126 | 0.064 | 0.138 | Histone deacetylase class III inhibitor | 0.138 0.054 CID_154699915 | CID_154699915 | |
| 0.105 | 0.044 | 0.128 | NMDA receptor antagonist | 0.128 0.032 CID_154699915 | CID_154699915 | |
| 0.08 | 0.02 | 0.08 | MDM2 inhibitor | 0.068 0.046 CID_154699915 | ||
| 0.107 | 0.046 | 0.11 | Protein kinase C delta inhibitor | 0.11 0.044 CID_154699915 | CID_154699915 | |
| 0.098 | 0.037 | 0.111 | Myeloperoxidase inhibitor | 0.111 0.025 CID_154699915 | CID_154699915 | |
| 0.098 | 0.039 | 0.142 | Carbonic anhydrase XIII inhibitor | 0.142 0.023 CID_154699915 | CID_154699915 | |
| 0.072 | 0.014 | 0.072 | Carbonic anhydrase IV inhibitor | 0.058 0.02 CID_154699915 | ||
| 0.084 | 0.027 | 0.084 | NMDA receptor agonist | |||
| 0.068 | 0.012 | 0.068 | Dihydroorotase inhibitor | 0.047 0.027 CID_154699915 | ||
| 0.163 | 0.106 | 0.163 | MAP kinase kinase 5 inhibitor | |||
| 0.072 | 0.016 | 0.084 | Beta 2 adrenoreceptor agonist | 0.084 0.007 CID_154699915 | CID_154699915 | |
| 0.059 | 0.004 | 0.059 | Elastase 2B inhibitor | 0.05 0.004 CID_154699915 | ||
| 0.059 | 0.004 | 0.059 | Elastase 3A inhibitor | 0.05 0.004 CID_154699915 | ||
| 0.059 | 0.004 | 0.059 | Elastase 3B inhibitor | 0.05 0.004 CID_154699915 | ||
| 0.111 | 0.056 | 0.111 | GABA C receptor agonist | |||
| 0.083 | 0.031 | 0.083 | ZAP-70 protein tyrosine kinase inhibitor | 0.079 0.037 CID_154699915 | ||
| 0.092 | 0.041 | 0.1 | D-Ala-D-Ala ligase inhibitor | 0.1 0.029 CID_154699915 | CID_154699915 | |
| 0.054 | 0.005 | 0.054 | CXC chemokine 2 receptor antagonist | 0.052 0.005 CID_154699915 | ||
| 0.12 | 0.07 | 0.12 | MAP kinase 12 inhibitor | |||
| 0.07 | 0.022 | 0.07 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 CID_154699915 | ||
| 0.083 | 0.036 | 0.089 | Alpha adrenoreceptor agonist | 0.089 0.033 CID_154699915 | CID_154699915 | |
| 0.184 | 0.137 | 0.219 | Superoxide dismutase inhibitor | 0.219 0.098 CID_154699915 | CID_154699915 | |
| 0.13 | 0.084 | 0.164 | Protein kinase stimulant | 0.164 0.059 CID_154699915 | CID_154699915 | |
| 0.086 | 0.041 | 0.117 | Keratolytic | 0.117 0.023 CID_154699915 | CID_154699915 | |
| 0.213 | 0.168 | 0.243 | Interleukin 2 agonist | 0.243 0.127 CID_154699915 | CID_154699915 | |
| 0.172 | 0.128 | 0.172 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.085 | 0.04 | 0.108 | NMDA 2 receptor antagonist | 0.108 0.028 CID_154699915 | CID_154699915 | |
| 0.187 | 0.144 | 0.187 | Neuropeptide Y2 antagonist | 0.179 0.163 CID_154699915 | ||
| 0.109 | 0.068 | 0.19 | Cystathionine beta-synthase inhibitor | 0.19 0.027 CID_154699915 | CID_154699915 | |
| 0.096 | 0.055 | 0.096 | ABCA1 expression enhancer | 0.093 0.061 CID_154699915 | ||
| 0.079 | 0.038 | 0.116 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 CID_154699915 | CID_154699915 | |
| 0.078 | 0.038 | 0.096 | Carbonic anhydrase VA inhibitor | 0.096 0.027 CID_154699915 | CID_154699915 | |
| 0.092 | 0.052 | 0.092 | Bromodomain-containing protein 2 inhibitor | |||
| 0.161 | 0.122 | 0.211 | Neurotrophic factor enhancer | 0.211 0.066 CID_154699915 | CID_154699915 | |
| 0.101 | 0.063 | 0.158 | 5-Lipoxygenase inhibitor | 0.158 0.035 CID_154699915 | CID_154699915 | |
| 0.085 | 0.048 | 0.085 | T cell inhibitor | |||
| 0.148 | 0.11 | 0.167 | Phospholipase C inhibitor | 0.167 0.078 CID_154699915 | CID_154699915 | |
| 0.093 | 0.056 | 0.093 | Polo-like kinase-1 inhibitor | 0.084 0.074 CID_154699915 | ||
| 0.086 | 0.049 | 0.104 | Estrogen-related receptor beta agonist | 0.104 0.02 CID_154699915 | CID_154699915 | |
| 0.066 | 0.03 | 0.08 | Carbonic anhydrase VB inhibitor | 0.08 0.022 CID_154699915 | CID_154699915 | |
| 0.072 | 0.036 | 0.092 | Beta adrenoreceptor antagonist | 0.092 0.02 CID_154699915 | CID_154699915 | |
| 0.123 | 0.089 | 0.123 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.107 CID_154699915 | ||
| 0.143 | 0.109 | 0.17 | Amyloid beta precursor protein antagonist | 0.17 0.081 CID_154699915 | CID_154699915 | |
| 0.048 | 0.014 | 0.048 | Potassium channel Kv1.1 blocker | 0.036 0.031 CID_154699915 | ||
| 0.073 | 0.04 | 0.096 | Carbonic anhydrase V inhibitor | 0.096 0.028 CID_154699915 | CID_154699915 | |
| 0.046 | 0.014 | 0.046 | Sirtuin 2 inhibitor | 0.036 0.02 CID_154699915 | ||
| 0.248 | 0.216 | 0.265 | Cyclophilin D inhibitor | 0.265 0.196 CID_154699915 | CID_154699915 | |
| 0.081 | 0.05 | 0.081 | MAP kinase 10 inhibitor | |||
| 0.078 | 0.047 | 0.09 | GABA B receptor agonist | 0.09 0.026 CID_154699915 | CID_154699915 | |
| 0.035 | 0.004 | 0.035 | Alpha 2b adrenoreceptor agonist | 0.026 0.005 CID_154699915 | ||
| 0.102 | 0.071 | 0.136 | DOPA decarboxylase inhibitor | 0.136 0.03 CID_154699915 | CID_154699915 | |
| 0.097 | 0.066 | 0.097 | Protein kinase (CK2) inhibitor | 0.087 0.076 CID_154699915 | ||
| 0.056 | 0.025 | 0.056 | Potassium channel (Inward rectifier) activator | |||
| 0.061 | 0.032 | 0.061 | Thromboxane antagonist | |||
| 0.057 | 0.028 | 0.057 | H+/K+-transporting ATPase inhibitor | 0.051 0.035 CID_154699915 | ||
| 0.078 | 0.049 | 0.078 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.064 CID_154699915 | ||
| 0.035 | 0.006 | 0.035 | Complement factor 1r inhibitor | 0.03 0.011 CID_154699915 | ||
| 0.053 | 0.024 | 0.053 | Potassium channel (ATP-sensitive) activator | |||
| 0.038 | 0.009 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.041 0.008 CID_154699915 | CID_154699915 | |
| 0.06 | 0.032 | 0.061 | Sphingosine kinase 2 inhibitor | 0.061 0.03 CID_154699915 | CID_154699915 | |
| 0.065 | 0.037 | 0.065 | Purinergic P2X1 antagonist | 0.064 0.038 CID_154699915 | ||
| 0.059 | 0.031 | 0.059 | Dihydroorotate oxidase inhibitor | 0.054 0.04 CID_154699915 | ||
| 0.078 | 0.051 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.027 CID_154699915 | CID_154699915 | |
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | |||
| 0.102 | 0.075 | 0.111 | Mucolytic | 0.111 0.064 CID_154699915 | CID_154699915 | |
| 0.046 | 0.019 | 0.046 | Potassium channel KCNQ activator | |||
| 0.046 | 0.019 | 0.046 | Delayed rectifier potassium channel activator | |||
| 0.13 | 0.105 | 0.13 | GABA C receptor rho-2 antagonist | 0.129 0.107 CID_154699915 | ||
| 0.122 | 0.097 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.117 0.106 CID_154699915 | ||
| 0.058 | 0.034 | 0.059 | Leukotriene C antagonist | 0.059 0.031 CID_154699915 | CID_154699915 | |
| 0.042 | 0.018 | 0.042 | Phosphoglycerate kinase inhibitor | 0.038 0.021 CID_154699915 | ||
| 0.127 | 0.103 | 0.127 | Tyrosine kinase inhibitor | |||
| 0.055 | 0.032 | 0.055 | Thromboxane A2 antagonist | |||
| 0.096 | 0.072 | 0.111 | Urease inhibitor | 0.111 0.054 CID_154699915 | CID_154699915 | |
| 0.108 | 0.085 | 0.108 | Transcription factor STAT6 inhibitor | 0.107 0.086 CID_154699915 | ||
| 0.047 | 0.024 | 0.056 | Beta adrenoreceptor agonist | 0.056 0.01 CID_154699915 | CID_154699915 | |
| 0.109 | 0.086 | 0.109 | Epidermal growth factor receptor kinase inhibitor | 0.105 0.091 CID_154699915 | ||
| 0.073 | 0.051 | 0.084 | CDC25A inhibitor | 0.084 0.039 CID_154699915 | CID_154699915 | |
| 0.032 | 0.01 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 CID_154699915 | CID_154699915 | |
| 0.084 | 0.063 | 0.084 | Histamine N-methyltransferase inhibitor | |||
| 0.053 | 0.032 | 0.067 | Beta 2 adrenoreceptor antagonist | 0.067 0.018 CID_154699915 | CID_154699915 | |
| 0.033 | 0.013 | 0.033 | MAP3K8 inhibitor | |||
| 0.083 | 0.063 | 0.083 | Insulin growth factor antagonist | |||
| 0.03 | 0.011 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.087 | 0.068 | 0.101 | Alcohol dehydrogenase inhibitor | 0.101 0.052 CID_154699915 | CID_154699915 | |
| 0.061 | 0.042 | 0.061 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.014 CID_154699915 | ||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.043 | 0.026 | 0.051 | Liver X receptor alpha agonist | 0.051 0.019 CID_154699915 | CID_154699915 | |
| 0.104 | 0.086 | 0.104 | Caspase 3 inhibitor | |||
| 0.076 | 0.058 | 0.076 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.076 0.058 CID_154699915 | ||
| 0.06 | 0.043 | 0.06 | Cyclin D1 inhibitor | 0.06 0.043 CID_154699915 | ||
| 0.043 | 0.026 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 CID_154699915 | ||
| 0.065 | 0.05 | 0.065 | Glutamate (mGluR6) antagonist | |||
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.164 | 0.15 | 0.187 | Spasmolytic | 0.187 0.131 CID_154699915 | CID_154699915 | |
| 0.124 | 0.109 | 0.124 | Thiol protease inhibitor | |||
| 0.078 | 0.064 | 0.078 | Insulin like growth factor 1 antagonist | |||
| 0.022 | 0.008 | 0.024 | Alpha 2a adrenoreceptor agonist | 0.024 0.007 CID_154699915 | CID_154699915 | |
| 0.213 | 0.199 | 0.336 | 15-Lipoxygenase inhibitor | 0.336 0.107 CID_154699915 | CID_154699915 | |
| 0.04 | 0.026 | 0.04 | GABA uptake inhibitor | |||
| 0.069 | 0.056 | 0.069 | Glycine receptor agonist | |||
| 0.068 | 0.056 | 0.068 | Aminopeptidase I inhibitor | |||
| 0.089 | 0.076 | 0.135 | Carbonic anhydrase III inhibitor | 0.135 0.035 CID_154699915 | CID_154699915 | |
| 0.029 | 0.018 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.053 | 0.042 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.048 | 0.037 | 0.048 | Potassium channel (Inward rectifier) blocker | |||
| 0.046 | 0.036 | 0.046 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.164 | 0.154 | 0.164 | Interleukin agonist | |||
| 0.024 | 0.014 | 0.024 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.02 | 0.011 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.048 | 0.039 | 0.048 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.06 | 0.051 | 0.069 | Leukotriene antagonist | 0.069 0.041 CID_154699915 | CID_154699915 | |
| 0.07 | 0.061 | 0.076 | GABA aminotransferase inhibitor | 0.076 0.051 CID_154699915 | CID_154699915 | |
| 0.085 | 0.077 | 0.085 | Aminopeptidase B inhibitor | |||
| 0.051 | 0.044 | 0.063 | Alcohol oxidase inhibitor | 0.063 0.033 CID_154699915 | CID_154699915 | |
| 0.167 | 0.159 | 0.168 | RNA-directed DNA polymerase inhibitor | 0.168 0.157 CID_154699915 | CID_154699915 | |
| 0.042 | 0.035 | 0.042 | Heme oxygenase inhibitor | |||
| 0.024 | 0.018 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.06 | 0.055 | 0.072 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 CID_154699915 | CID_154699915 | |
| 0.145 | 0.141 | 0.145 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.039 | 0.036 | 0.047 | NMDA receptor subunit 3B antagonist | 0.047 0.027 CID_154699915 | CID_154699915 | |
| 0.06 | 0.057 | 0.06 | Phosphodiesterase 4B inhibitor | |||
| 0.015 | 0.012 | 0.015 | Thromboxane A2 agonist | |||
| 0.033 | 0.031 | 0.042 | NMDA receptor subunit 3A antagonist | 0.042 0.024 CID_154699915 | CID_154699915 | |
| 0.092 | 0.091 | 0.092 | GABA C receptor antagonist | |||
| 0.081 | 0.079 | 0.114 | Breast cancer-resistant protein inhibitor | 0.114 0.044 CID_154699915 | CID_154699915 | |
| 0.141 | 0.139 | 0.141 | EphB2 antagonist | |||
| 0.063 | 0.062 | 0.063 | Catalase inhibitor | |||
| 0.043 | 0.043 | 0.058 | Carbonic anhydrase XIV inhibitor | 0.058 0.026 CID_154699915 | CID_154699915 | |
| 0.21 | 0.213 | 0.338 | Alpha-glucosidase inhibitor | 0.338 0.142 CID_154699915 | CID_154699915 | |
| 0.047 | 0.052 | 0.051 | Cyclin B2 inhibitor | 0.051 0.046 CID_154699915 | CID_154699915 | |
| 0.019 | 0.024 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.012 CID_154699915 | CID_154699915 | |
| 0.023 | 0.028 | 0.026 | Liver X receptor beta antagonist | 0.026 0.023 CID_154699915 | CID_154699915 | |
| 0.189 | 0.195 | 0.249 | Apoptosis antagonist | 0.249 0.129 CID_154699915 | CID_154699915 | |
| 0.068 | 0.075 | 0.074 | Phosphodiesterase IV inhibitor | 0.074 0.068 CID_154699915 | CID_154699915 | |
| 0.095 | 0.101 | 0.171 | Amylase inhibitor | 0.171 0.055 CID_154699915 | CID_154699915 | |
| 0.05 | 0.058 | 0.054 | Cyclin B1 inhibitor | 0.054 0.052 CID_154699915 | CID_154699915 | |
| 0.036 | 0.045 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.034 CID_154699915 | CID_154699915 | |
| 0.024 | 0.035 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.017 CID_154699915 | CID_154699915 | |
| 0.124 | 0.135 | 0.14 | MAP kinase kinase 4 inhibitor | 0.14 0.083 CID_154699915 | CID_154699915 | |
| 0.102 | 0.114 | 0.138 | Alkaline phosphatase inhibitor | 0.138 0.069 CID_154699915 | CID_154699915 | |
| 0.112 | 0.125 | 0.152 | Farnesoid X receptor antagonist | 0.152 0.05 CID_154699915 | CID_154699915 | |
| 0.146 | 0.162 | 0.18 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.18 0.093 CID_154699915 | CID_154699915 | |
| 0.014 | 0.031 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.013 CID_154699915 | CID_154699915 | |
| 0.062 | 0.083 | 0.112 | Macrophage migration inhibitory factor inhibitor | 0.112 0.029 CID_154699915 | CID_154699915 | |
| 0.053 | 0.074 | 0.078 | Histidine decarboxylase inhibitor | 0.078 0.044 CID_154699915 | CID_154699915 | |
| 0.039 | 0.061 | 0.055 | Maillard reaction inhibitor | 0.055 0.038 CID_154699915 | CID_154699915 | |
| 0.115 | 0.138 | 0.151 | Heat shock protein 90 alpha antagonist | 0.151 0.086 CID_154699915 | CID_154699915 | |
| 0.054 | 0.081 | 0.072 | Glutamate decarboxylase inhibitor | 0.072 0.052 CID_154699915 | CID_154699915 | |
| 0.039 | 0.068 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.06 0.029 CID_154699915 | CID_154699915 | |
| 0.025 | 0.054 | 0.039 | Estrogen-related receptor beta antagonist | 0.039 0.012 CID_154699915 | CID_154699915 | |
| 0.119 | 0.148 | 0.143 | CF transmembrane conductance regulator agonist | 0.143 0.089 CID_154699915 | CID_154699915 | |
| 0.025 | 0.055 | 0.03 | Protein kinase C beta II inhibitor | 0.03 0.029 CID_154699915 | CID_154699915 | |
| 0.08 | 0.11 | 0.109 | Beta glucuronidase inhibitor | 0.109 0.057 CID_154699915 | CID_154699915 | |
| 0.083 | 0.114 | 0.099 | Cholesterol synthesis inhibitor | 0.099 0.089 CID_154699915 | CID_154699915 | |
| 0.026 | 0.059 | 0.045 | Dopamine D5 agonist | 0.045 0.022 CID_154699915 | CID_154699915 | |
| 0.112 | 0.145 | 0.13 | Adenylate cyclase stimulant | 0.13 0.101 CID_154699915 | CID_154699915 | |
| 0.092 | 0.127 | 0.189 | Lipid peroxidase inhibitor | 0.189 0.046 CID_154699915 | CID_154699915 | |
| 0.106 | 0.144 | 0.141 | Heat shock protein 90 antagonist | 0.141 0.084 CID_154699915 | CID_154699915 | |
| 0.128 | 0.168 | 0.144 | Neurotensin receptor agonist | 0.144 0.118 CID_154699915 | CID_154699915 | |
| 0.077 | 0.127 | 0.163 | M18 aspartyl aminopeptidase inhibitor | 0.163 0.046 CID_154699915 | CID_154699915 | |
| 0.044 | 0.109 | 0.07 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.07 0.061 CID_154699915 | CID_154699915 | |
| 0.068 | 0.144 | 0.109 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.109 0.092 CID_154699915 | CID_154699915 | |
| 0.198 | 0.277 | 0.275 | Calcium channel L-type activator | 0.275 0.18 CID_154699915 | CID_154699915 | |
| 0.076 | 0.161 | 0.11 | Toll-Like receptor 2 antagonist | 0.11 0.089 CID_154699915 | CID_154699915 | |
| 0.1 | 0.186 | 0.135 | Melanin inhibitor | 0.135 0.106 CID_154699915 | CID_154699915 | |
| 0.069 | 0.156 | 0.091 | Toll-Like receptor 4 antagonist | 0.091 0.088 CID_154699915 | CID_154699915 | |
| 0.051 | 0.151 | 0.086 | Bronchodilator | 0.086 0.079 CID_154699915 | CID_154699915 | |
| 0.079 | 0.194 | 0.202 | Amyloid beta aggregation inhibitor | 0.202 0.077 CID_154699915 | CID_154699915 | |
| 0.041 | 0.158 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 CID_154699915 | CID_154699915 | |
| 0.035 | 0.158 | 0.07 | Topoisomerase II alpha inhibitor | 0.07 0.062 CID_154699915 | CID_154699915 | |
| 0.091 | 0.273 | 0.237 | Antioxidant | 0.237 0.091 CID_154699915 | CID_154699915 | |
| 0.056 | 0.276 | 0.108 | Interleukin 4 antagonist | 0.108 0.104 CID_154699915 | CID_154699915 | |
| 0.048 | 0.302 | 0.128 | Estrogen antagonist | 0.128 0.042 CID_154699915 | CID_154699915 | |
| 0.122 | 0.416 | 0.24 | Apoptosis agonist | 0.24 0.225 CID_154699915 | CID_154699915 | |
| 0.055 | 0.357 | 0.203 | Free radical scavenger | 0.203 0.095 CID_154699915 | CID_154699915 | |
| 0.03 | 0.367 | 0.112 | Estrogen receptor beta antagonist | 0.112 0.043 CID_154699915 | CID_154699915 | |
| 0.083 | 0.45 | 0.204 | Sodium/bile acid cotransporter inhibitor | 0.204 0.183 CID_154699915 | CID_154699915 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |